• ‘Covid-friendly’ regimens – what is your experience?

‘Covid-friendly’ regimens – what is your experience?

Please let us know how many patients you gave single-agent immunotherapy when you would have planned treatment with combination-immunotherapy during the Covid pandemic.

We would like to build up a picture of how many patients this has affected in the UK and whether a proportion of these patients could subsequently be treated with the original intended regimen.


    printer-friendly version